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Abstract: PURPOSE Spinal epidural lipomatosis (SEL) is defined as an abnormal and extensive accu-
mulation of unencapsulated adipose tissue within the spinal epidural space. To date, there is a lack of
high-level evidence studies reporting the outcome of surgical treatment of symptomatic SEL in patients
with lumbar spinal stenosis (LSS). The aim was to compare clinical outcomes in patients with symp-
tomatic LSS with and without SEL who underwent decompression surgery alone at the 12- and 24-month
follow-up. METHODS One hundred and eighty-three patients met the inclusion criteria, of which 14 had
mainly SEL on at least one level operated in addition to possible degenerative changes on other levels and
169 degenerative LSS only. The main outcomes were pain (Spinal Stenosis Measure (SSM) symptoms),
disability (SSM function), and quality of life [EQ-5D-3L summary index (SI)] at 24-month follow-up,
and minimal clinically important difference (MCID) in SSM symptoms, SSM function, and EQ-5D-3L
SI. RESULTS The multiple regression linear models showed that SEL was associated with worse SSM
symptoms (p = 0.045) and EQ-5D-3L SI scores (p = 0.026) at 24-month follow-up, but not with worse
SSM function scores. Further, depression (in all models) was negatively associated with better clinical
outcomes at 24-month follow-up. In the outcomes SSM symptoms and EQ-5D-3L SI, distinctly more
patients in the classical LSS group reached MCID than in the SEL group (71.3% and 62.3% vs. 50.0%
and 42.9%). CONCLUSIONS Our study demonstrated that decompression alone surgery was associated
with significant improvement in disability in both groups at 2 years, but not in pain and quality of life
in patients with SEL.
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Abstract 
Purpose: Spinal epidural lipomatosis (SEL) is defined as an abnormal and extensive accumu-
lation of unencapsulated adipose tissue within the spinal epidural space. To date, there is a 
lack of high-level evidence studies reporting the outcome of surgical treatment of symptomat-
ic SEL in patients with lumbar spinal stenosis (LSS). The aim was to compare clinical out-
comes in patients with symptomatic LSS with and without SEL who underwent decompres-
sion surgery alone at the 12- and 24-month follow-up. 
Methods: One hundred eighty-three patients met the inclusion criteria, of which 14 had main-
ly SEL on at least one level operated in addition to possible degenerative changes on other 
levels and 169 degenerative LSS only. The main outcomes were pain (Spinal Stenosis Meas-
ure (SSM) symptoms), disability (SSM function), and quality of life (EQ-5D-3L summary 
index (SI)) at 24-month follow-up, and minimal clinically important difference (MCID) in 
SSM symptoms, SSM function, and EQ-5D-3L SI. 
Results: The multiple regression linear models showed that SEL was associated with worse 
SSM symptoms (p = 0.045) and EQ-5D-3L SI scores (p = 0.026) at 24-month follow-up, but 
not with worse SSM function scores. Further, depression (in all models), was negatively asso-
ciated with better clinical outcomes at 24-month follow-up. In the outcomes SSM symptoms 
and EQ-5D-3L SI, distinctly more patients in the classical LSS group reached MCID than in 
the SEL group (71.3% and 62.3% versus 50.0% and 42.9%). 
Conclusions: Our study demonstrated that decompression alone surgery was associated with 
significant improvement in disability in both groups at 2 years, but not in pain and quality of 
life in patients with SEL. 
 




Spinal epidural lipomatosis (SEL) is a rare disorder that leads to an abnormal and vast accu-
mulation of unencapsulated fatty tissue within the spinal epidural space. Its prevalence has 
been reported between the unknown and 2.5% [1]. When symptomatic, SEL can produce clin-
ical manifestations, such as radiculopathy, back pain, or neurogenic claudication by com-
pressing the spinal cord and/or roots [2]. The cause of SEL can be either idiopathic or second-
ary. The most common secondary etiology is due to exogenous long-term steroid use [3], fol-
lowed by obesity [4]. Less common are endogenous steroid exposure such as Cushing’s syn-
drome or other forms of hypercorticolism [5]. According to the literature, thoracic SEL is 
more frequently associated with steroid use and lumbar SEL cases are more of an idiopathic 
nature [6]. The most appropriate modality for evaluating fatty tissue and hence diagnosing 
SEL is magnetic resonance imaging (MRI) [7]. On T1-weighted images, epidural fat can be 
differentiated from dural content with high sensitivity [8]. A specific and typical sign of SEL 
is the Y sign as described by Kuhn presenting as a Y-shaped thecal sac compression by the 
excessive fat tissue not observed in other spinal pathologies [9]. 
There are different treatment strategies for symptomatic SEL, depending on the underlying 
conditions. Weight loss for obese patients [10], cessation of steroid use, or pharmaceutical 
pain management have been reported to be effective conservative treatment options [11]. If 
conservative treatment fails or patients present with abnormal or progressive neurological 
signs, surgical procedures offer a viable alternative [6]. To date, there is still a lack of studies 
with a high level evidence, reporting the outcome of surgical treatment of symptomatic SEL 
[12-14], except one recently published prospective study [15] concluding that “fat does not 
matter”. 
SEL may mimic other common spine conditions [16] and has been considered as a possible 
cause for symptomatic lumbar spinal stenosis (LSS) [17]. Therefore, the aim of our study is to 
compare clinical outcomes following decompression surgery for symptomatic LSS in patients 
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For this analysis, we used data from the Lumbar Stenosis Outcome Study (LSOS). The LSOS 
is conducted as a prospective cohort study in the Rheumatology and Spine Surgery Units at 
eight medical centers (which service a region in Switzerland with approximately two million 
inhabitants). Additional information about and inclusion criteria of LSOS is available else-
where [18]. 
 
Eligibility criteria for being included in this analysis 
All patients who met the inclusion criteria and underwent solely decompression surgery with 
symptomatic LSS caused either mainly by SEL on at least one operated level or by degenera-
tive changes only (“classical” LSS), had a BMI of ≥25 kg/m2 and were eligible on a 24-month 
follow-up. None of the patients had prior lumbar spine surgery.  
SEL was diagnosed with the help of preoperative MRI scans. Patients were included in the 
SEL group if mainly unencapsulated fatty tissue within the spinal epidural space led to a 
compression of the dural sac on at least one operated level. Patients in the SEL group might 
have had stenosis on other levels caused by degenerative changes only that could have also 
been decompressed during the same operation if they were possible causes for the complaints. 
 
Radiological classification 
Two radiologists evaluated the baseline MRI of each patient. They categorized the grading of 
the SEL of each level either according to Ishikawa et al. [4] into “Grade 0” (no dorsal epidural 
fat [EF]), “Grade 1” (EF observed within the border between the anterosuperior edges of the 
upper and lower neighboring neural arches, “concave”), “Grade 2” (EF observed over the 
border at the middle but not at the edges of neural arches on both sides, “flat”), and “Grade 3” 
(EF observed over the border at the edges of neural arches on at least one side, “convex or Y-
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sign”) or according to Borré et al. [8] into “normal” (EF to spinal canal index ≤40%, normal 
amount of EF), “grade 1” (EF to spinal canal index 41-50%, mild overgrowth of EF), “grade 
2” (EF to spinal canal index 51-74%, moderate overgrowth of EF), and “grade 3” (EF to spi-
nal canal index ≥75%, severe overgrowth of EF). 
Five core parameters according to the consensus paper of Andreisek et al. [19] were used 
to verify and to describe the severity of lumbar spinal stenosis: 1) compromise of the central 
zone , 2) relation between the cerebrospinal fluid and the cauda equina (Schizas classification) 
[20], 3) nerve root compression in the lateral recesses , 4) foraminal nerve root impingement 
[21], and 5) compromise of the foraminal zone. The first two refer to central stenosis, the third 
to lateral stenosis, and the last two to foraminal stenosis. The Meyerding classification was 
used to grade the severity of the spondylolisthesis [22]. 
 
Surgical technique / approach 
Surgery consisted of a standard open posterior lumbar laminotomy at the affected level / lev-
els without instrumentation. The decision to proceed with a laminotomy with a unilateral 
technique to decompress the fatty tissue or a midline approach with bilateral laminotomy was 
at the surgeons' discretion. The decision to use an operating microscope and to proceed with a 
single or two-level procedure was also at the surgeons' discretion. The procedures were con-
ducted or supervised by senior neuro- or orthopedic surgeon with more than 10 years of expe-
rience after board certification. 
Reoperation is defined as a renewed operation on at least one level that was operated be-
fore. In case a fusion procedure was necessary, the operation could have been extended to 
other levels. Reoperations that took place within three months after initial operation were not 




Spinal Stenosis Measure (SSM): The SSM is a self-administered validated three-part ques-
tionnaire that was specifically designed for DLSS patients to measure the severity of symp-
toms and patient disability [23]. It is widely used in studies on DLSS and recommended by 
the North American Spine Society (NASS). It consists of three different subscales; the symp-
tom severity subscale, the physical function subscale and the satisfaction subscale. The sub-
scale score ranges are 1−5, 1−4 and 1−4 (best-worst). Minimal clinically important difference 
(MCID) in SSM symptoms is defined as an improvement (decrease) by at least 0.48 points 
and in SSM function improvement as by at least 0.52 points [24]. 
EQ-5D-3L: The EuroQol five-dimensional self-administered questionnaire (EQ-5D) is a 
standardized instrument to measure health-related quality of life and was developed by the 
EuroQol Group [25]. The first element, the EQ-5D descriptive system, measures the health 
state in five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxie-
ty/depression) with three levels of severity for each dimension (EQ-5D-3L). With the help of 
a value set (depending on population norms), the health state can be converted into a single 
summary index (SI) value. This value can range from -0.53 (for the French population) to 1, 
with 0 representing a health state equivalent to being dead and 1 indicating full health. The 
French value set was used to the calculation of summary index, as there is no specific value 
set for Switzerland [26]. MCID is defined as an improvement (increase) by at least 0.19 points 
[submitted]. The second element, the EQ-5D Visual Analogue Scale (VAS), measures the 
health status on a vertical scale between 0 and 100 (worst to best imaginable health state) on a 




The main outcomes of this study are SSM symptoms, SSM function, and EQ-5D-3L SI at 24-
month follow-up, and MCID in SSM symptoms, SSM function, and EQ-5D-3L SI from base-
line to 24-month follow-up. 
 
Ethics 
This multi-center cohort study was conducted in compliance with all international laws and 
regulations as well as any applicable guidelines. Written informed consent to participate in the 
study has been obtained from participants. The study was approved by the independent Ethics 
Committee of the Canton Zurich (KEK-ZH-NR: 2010-0395/0). 
 
Statistical analysis 
Baseline: Baseline patient information is presented as means/standard deviations and 
counts/percentages as appropriate. Patient demographics, health information, baseline out-
come scores, as well as radiological parameters are reported for the SEL and classical LSS 
groups. Additionally, a summary of the operations and complications is presented. Chi-
squared and t-test results are reported for each comparison. All analyses were conducted with 
R for Windows [27]. 
Unadjusted analysis: An initial unadjusted analysis uses t-tests to determine if there is any 
evidence for change from baseline to the 24-month follow-up in the three outcomes and in the 
two groups. 
Multiple imputation: A small number of patients had missing values in some of their base-
line data (depression, gonarthrosis, coxarthrosis). Ten complete datasets were generated based 
on multiple imputation with chained equations to be used for further analysis [28]. 
Adjusted analysis: To properly quantify the effect of SEL on patient outcomes, we con-
structed linear regression models for each of the outcomes at 24 months, which included SEL, 
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the baseline outcome score, age, BMI, sex, CIRS, depression, number of levels decompressed, 
and epidural injection within 6 months before baseline. These factors are considered influen-
tial on outcomes of spinal surgery. The estimated model coefficients were pooled using Ru-




Figure 1 shows the patient flow of 841 patients who agreed to participate between December 
2010 and December 2015. For this analysis, 183 patients met the inclusion criteria; 14 pa-
tients in the SEL group and 169 patients in the classical LSS group. 
Table 1 presents the patient characteristics at baseline. Mean age was 75.4 years for the 
SEL group and 72.6 years for the classical LSS group. The percentage of men was 64.3% and 
55.6%, respectively. Only one patient in the classical LSS group was taking glucocorticoid 
medication and none of the patients suffered from endogenous steroid overproduction. The 
only statistically significant difference between the groups was in the depression subscore of 
HADS (p = 0.037).  
 
Lipomatosis grading and morphological findings on MRI 
All patients in the SEL group demonstrated a Grade 3 in one of the two grading scores (Borré 
or Ishikawa classification) and at least a Grade 2 in the other grading score on at least one 
operated level. Of the 14 patients in the SEL group, 11 (78.6%) had an isolated epidural li-
pomatosis (1 on L2/L3, 2 on L3/L4, and 8 on L4/L5), 2 (14.3%) presented with a SEL at the 
lumbosacral junction, and 1 (7.1%) suffered from a multisegmental SEL. Figure 2 displays 
representative initial MRI scans of a SEL patient (A, B) and a classical DLSS (C, D) patient. 
Table 2 provides details about morphological findings on MRI. Most patients in both 
groups had the stenotic level (at least one moderate grading in the central or lateral core pa-
rameters) at L4/L5, followed by L3/L4 and L5/S1. Furthermore, the highest stenotic grading 
was severe in both groups with more than 90% and 85%, respectively. Also, there were no 
significant differences in degenerative spondylolisthesis between the groups. 
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Surgical treatment, peri- and postoperative surgical complications, and reoperations 
Four (28.6%) patients in the SEL group received a unilateral laminotomy with bilateral de-
compression initially, as compared with a total of 86 patients (50.9 %) in the classical LSS 
group. The most frequently decompressed level was L4/L5, followed by L3/L4, and in both 
groups, most patients underwent a two-level decompression (Table 3). The most common 
intraoperative complication was a dural tear in both groups (6.5% versus 7.1%).  
In the SEL group, two reoperations were performed in two patients (14.3%). The corre-
sponding numbers for the classical LSS group were 29 reoperations in 23 patients (13.6%). 
Over 90% of the patients were reoperated due to restenosis and half of the reoperations were 
preceded within the first year after the initial operation (Table 3). 
 
MCID and mean changes in all outcomes at 24-month follow-up 
In the outcomes SSM symptoms and EQ-5D-3L SI, distinctly more patients in the classical 
LSS group reached MCID than in the SEL group (71.0% and 62.1% versus 50.0% and 
42.9%), whereas in SSM function almost as many patients improved in both groups (65.7% 
versus 64.3%).  
The mean changes between baseline and the 24-month follow-up in the SEL group were 
below the corresponding MCID values at all outcomes, whereas in the classical LSS group 
above the corresponding MCID values (Table 4). However, there was a distinct improvement 
after two years in all outcomes except for the quality of life in the SEL group. Figure 3 shows 
all clinical outcome measures over time with boxplots. 
 
Multiple linear regression models for all outcomes at 24-month follow-up 
The multiple linear regression models showed that SEL was associated with worse SSM 
symptoms (p = 0.045) and EQ-5D-3L SI scores (p = 0.028) at the 24-month follow-up, but 
not with worse SSM function scores. Furthermore, depression (in all models), age (in SSM 
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function), BMI (in SSM function), and CIRS (in SSM symptoms) were negatively associated 
with better clinical outcomes at the 24-month follow-up.  
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Discussion 
Our analyses demonstrate that, compared to patients with classical degenerative LSS undergo-
ing decompression alone surgery, patients with symptomatic LSS caused mainly by SEL on at 
least one operated level in addition to degenerative changes on other levels experienced more 
pain (SSM symptoms) and were more dissatisfied with their quality of life (EQ-5D-3L SI). 
They did not have less function (SSM function) at 24-month follow-up. 
There is a lack of high level of evidence studies analyzing the effect of decompression sur-
gery comparing patients with LSS caused by SEL versus caused by degenerative changes on-
ly. To our knowledge, there is only one prospective study by Bayerl et al. [15] who reported 
in their prospective study with 89 patients no difference in pain, walking distance, function, 
and quality of life after 3-year follow-up between patients with SEL compared to without SEL 
undergoing decompressive microsurgery. Our results do not fully support the findings. A pos-
sible reason for the difference in quality of life could be the lower mean age in their SEL 
group (70.0±8.3 vs 75.4±6.9 years in our study). On the other hand, there are a few studies 
with a lower level of evidence. A matched-cohort study [11] with 28 patients found weak evi-
dence for less satisfaction after surgery in the SEL group, however, it is not clearly evident at 
what time point the outcome was exactly assessed what consequently hampers comparison 
with our results. Further, a retrospective analysis of prospectively collected data of a single 
center spine database with no control group reported an improvement in patient-rated out-
comes scores (leg and back pain, Core Outcome Measures Index (COMI) which comprises 
among others back-related function and general quality of life) up to two years postoperative-
ly [12].  
In the current literature, there are a few factors discussed to be associated with SEL such as 
obesity, systemic corticosteroid use, and epidural corticosteroid injections [3, 6, 16, 30]. In a 
retrospective study reviewing nearly 29’000 spine MRIs, the aforementioned factors as well 
as older age and male sex were found to have an association with SEL with spine-related 
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symptoms in a multivariate analysis (in 35% the lipomatosis was solely located in the lumbar 
region, in 59% in multiple spine regions) [1]. However, in our study, all these factors did not 
differ between the groups at baseline.  
Lumbar spinal degenerative changes in the discs, ligamentum flavum, and facet joints are 
present in more than 80% of patients aged 70 years and more [31] whereas SEL is a rare dis-
ease with a prevalence rate around 6% in patients with LSS [32]. Both pathologies can lead to 
a narrowing of the spinal canal with or without clinical symptoms. Therefore, elderly patients 
with neurogenic claudication caused only by SEL and no concomitant degenerative changes is 
an very uncommon event as reported by Malone et al. [32], even SEL has a different origin 
than degenerative pathology as discussed above and in the introduction. Further, Bayerl et al. 
[15] showed in their study that surgical decompression in patients with SEL is an effective 
procedure if conservative treatment failed. 
To an extent, it is still not clear why quality of life (EQ-5D-3L SI) responses turned out to 
be lower. It may be that other types of noncompressive spinal disease could have caused the 
symptoms experienced following surgery. Some subjects could have had additional changes 
to facet joints or discs that were not noticed on MRI scans but still inflicted pain and/or disa-
bility. These long-term degenerative changes could have caused the low level of response, 
particularly with the follow-up in the longer term. 
Spinal fusion was an exclusion criterion in this study, as the intention was to exclusively 
evaluate the effects of decompression surgery. The majority of patients were treated with 
open bilateral decompression or unilateral decompression (using over-the-top techniques) to 
remove fatty tissue.  
One strength of our study is that a pair of radiologists undertook the evaluation of the MRI 
data, which allowed for a robust evaluation of SEL. The LSOS study was originally not in-
tended to compare LSS and SEL patients, which is a weakness of our conclusion. Further-
more, the SEL patient group was relatively small (14 patients), which limited the possibility 
 15 
to detect differences. Also the multi-center nature of our study with various but very experi-
enced surgeons might have had an influence on our results. Further, patients in the classical 
LSS group had a lower extent of surgical invasiveness and less degenerative changes that 
could have influenced the outcomes. 
 
Conclusion 
Our study demonstrated that decompression alone surgery was associated with significant 
improvement in disability in both groups at 2-year follow-up, but not in pain and quality of 
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Table 1: Patient characteristics at baseline 
Variable Classical LSS SEL p 
n 169 14  
Age, years, mean (SD) 72.64 (8.34) 75.36 (6.91) 0.237 
Female, n (%) 75 (44.4) 5 (35.7) 0.728 
BMI, kg/m2, mean (SD) 29.66 (3.81) 30.23 (2.57) 0.581 
BMI >30, kg/m2, n (%) 65 (38.5) 9 (64.3) 0.108 
Current Smoker, n (%) 23 (13.6) 2 (14.3) 1.000 
Civil Risk*, n (%) 60 (35.5) 4 (28.6) 0.817 
Compulsory Education, n (%) 48 (28.4) 1 (7.1) 0.158 
Diabetes mellitus, n (%) 26 (15.4) 2 (14.3) 1.000 
Taking glucocorticoid medication, n (%) 1 (0.6) 0 (0.0) 1.000 
Duration of symptoms > 6 months, n (%) 150 (89.8) 13 (92.9) 1.000 
Back pain, n (%) 142 (84.0) 14 (100.0) 0.220 
Buttocks pain, n (%) 135 (79.9) 10 (71.4) 0.684 
Leg pain, n (%) 155 (91.7) 12 (85.7) 0.786 
Coxarthrosis, n (%) 24 (14.5) 2 (14.3) 1.000 
Gonarthrosis, n (%) 36 (21.7) 4 (28.6) 0.795 
Problem getting better or worse in the last 3 mo, n (%)   0.419 
   Getting better 11 (6.5) 0 (0.0)  
   Staying about the same 24 (14.2) 4 (28.6)  
   Getting worse 133 (78.7) 10 (71.4)  
   Don’t know 1 (0.6) 0 (0.0)  
CIRS (mean (SD)) 9.42 (3.72) 10.64 (4.92) 0.251 
HADS depression, mean (SD) 4.67 (3.25) 6.64 (4.62) 0.037 
SSM function, mean (SD)*1 2.34 (0.68) 2.43 (0.54) 0.647 
SSM symptoms, mean (SD)*2 3.17 (0.60) 3.26 (0.67) 0.599 
EQ-5D-3L SI, mean (SD)*3 0.47 (0.29) 0.46 (0.31) 0.853 
Epidural injection within 6 months before baseline, n (%) 47 (27.8) 6 (42.9) 0.376 






BMI, body mass index kg/m2; HADS, Hospital Anxiety and Depression Scale (range 0-21, best-worst); CIRS, Cumulative Illness Rating 
Scale (range 0-56, best-worst); SI, summary index; SSM, Spinal Stenosis Measure 
* Living alone, or single/divorced/widowed and living in a nursing/residential home; *1 score range 1-4 (best-worst); *2 score range 1-5 
(best-worst); *3 score range -0.53-1.00 (worst-best) 
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Table 2: Radiologic evaluations of the MRIs 
Variable Classical LSS SEL p 
n 169 14  
Stenosis levels*, n (%)    
   L1/L2 52 (30.8) 4 (28.6) 1.000 
   L2/L3 97 (57.4) 11 (78.6) 0.206 
   L3/L4 145 (85.8) 11 (78.6) 0.733 
   L4/L5 161 (95.3) 14 (100.0) 0.879 
   L5/S1 111 (65.7) 11 (78.6) 0.491 
No. stenotic levels*, n (%)   NaN 
   0 0 (0.0) 0 (0.0)  
   1 14 (8.3) 0 (0.0)  
   2 31 (18.3) 3 (21.4)  
   3 37 (21.9) 1 (7.1)  
   4 56 (33.1) 8 (57.1)  
   5 31 (18.3) 2 (14.3)  
Central stenosis*1, n (%) 163 (96.4) 14 (100.0) 1.000 
Lateral stenosis*2, n (%) 166 (98.2) 13 (92.9) 0.712 
Foraminal stenosis*3, n (%) 156 (92.3) 14 (100.0) 0.592 
Highest stenotic grading*4, n (%)   NaN 
   None 0 (0.0) 0 (0.0)  
   Mild 1 (0.6) 0 (0.0)  
   Moderate 15 (8.9) 2 (14.3)  
   Severe 153 (90.5) 12 (85.7)  
Spondylolisthesis*5, n levels (%)    
   L1/L2 8 (4.7) 2 (14.3) 0.368 
   L2/L3 10 (5.9) 2 (14.3) 0.513 
   L3/L4 38 (22.5) 2 (14.3) 0.706 
   L4/L5 61 (36.1) 3 (21.4) 0.416 
   L5/S1 32 (18.9) 2 (14.3) 0.942 
* at least one moderate grading in one of the following core parameters: compromise of the central zone, relation between fluid and cauda 
equina (Schizas classification), and nerve root compression in the lateral recesses; *1 at least one moderate grading in one of the following 
core parameters: compromise of the central zone, relation between fluid and cauda equina (Schizas classification); *2 at least one moderate 
grading in the following core parameter: nerve root compression in the lateral recesses; *3 at least one moderate grading in one of the follow-
ing core parameters: foraminal nerve root impingement and compromise of the foraminal zone; *4 highest grading in one of the three core 
parameters (central, lateral) on all levels, *5 Meyerding listhesis grade ≥1  
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Table 3: Peri- and postoperative surgical complications and reoperations 
Variable Classical LSS SEL p 
n 169 14  
Decompression level, n (%)    
   L1/L2 5 (3.0) 0 (0.0) 1.000 
   L2/L3 47 (27.8) 4 (28.6) 1.000 
   L3/L4 110 (65.1) 10 (71.4) 0.852 
   L4/L5 129 (76.3) 13 (92.9) 0.275 
   L5/S1 23 (13.6) 4 (28.6) 0.261 
Levels decompressed, n (%)   0.210 
   1 64 (37.9) 2 (14.3)  
   2 71 (42.0) 8 (57.1)  
   3+ 34 (20.1) 4 (28.6)  
Complications, n (%)    
   Intraoperative bleeding 4 (2.4) 0 (0.0) 1.000 
   Intraoperative dural tear 11 (6.5) 1 (7.1) 1.000 
   Postoperative wound infection 2 (1.2) 0 (0.0) 1.000 
   Postoperative osseous infection 1 (0.6) 0 (0.0) 1.000 
   Postoperative other* 16 (9.5) 1 (7.1) 1.000 
Days between baseline and operation, median [IQR] 11.00 [3.00, 30.00] 38.50 [24.25, 66.25] 0.007 
No. of reoperations in total, n (%) 29 2  
   Patients with   0.774 
      1 reoperation, n (%) 23 (79.3) 2 (100.0)  
      2 reoperations, n (%) 5 (17.2) 0 (0.0)  
      3 reoperations, n (%) 1 (3.4) 0 (0.0)  
   Indication: restenosis 26 (89.7) 2 (100.0) 1.000 
   Indication: infection 1 (3.42) 0 (0.0) 1.000 
   Indication: epidural bleeding 2 (6.9) 0 (0.0) 1.000 
   During the 1st year 16 (55.2) 1 (50.0) 1.000 
   During the 2nd year 9 (31.0) 1 (50.0) 1.000 
   During the 3rd year 4 (13.8) 0 (0.0) 1.000 











NA [NA, NA] NA 




NA [NA, NA] NA 




Table 4: Mean changes for all outcomes at 24-month follow-up 






SEL, mean (SE) p-
value* 
n 169  14  
SSM function -0.74 (0.058) <0.001 -0.47 (0.12) 0.0019 
SSM symptoms -0.96 (0.066) <0.001 -0.47 (0.21) 0.042 
EQ-5D-3L SI 0.28 (0.026) <0.001 0.084 (0.069) 0.24 
MCID, minimal clinically important difference; SI, summary index; SSM, Spinal Stenosis Measure 




Figure 1: Study flow 
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Figure 2: Representative lumbar spine MRI scans of a SEL patient (A, B) and a classical 
DLLS-patient (C, D).  
 
A. Sagittal T1-weighted MRI shows a monosegmental lipomatosis on level L5/S1. 
B. Corresponding axial T2-weighted MRI shows the highly stenotic level on L5/S1 due to epidural lipomatosis.  
C. Sagittal T2-weighted MRI shows a classical DLSS patient with a monosegmental degenerative stenosis on level L4/5. 
D. T1-weighted axial image with the most stenotic level on level L4/L5 due to disc protrusion and hypertrophy of the ligamentum flavum. 
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Appendix Table 1a: Multiple linear regression model for SSM function at 24-month fol-
low-up 
Variable estimate std.error statistic df p.value 
(Intercept) 1.834 0.120 15.321 171.017 0.000 
Age 0.011 0.005 2.068 170.914 0.040 
BMI 0.033 0.011 2.898 170.521 0.004 
SEL 0.236 0.159 1.477 170.810 0.141 
SSM function 0.269 0.066 4.072 170.663 0.000 
Male -0.155 0.087 -1.777 170.584 0.077 
Epidural injection 
within 6 months be-
fore baseline 
-0.027 0.092 -0.299 170.696 0.765 
CIRS 0.018 0.011 1.575 170.746 0.117 
HADS depression 0.034 0.013 2.531 164.099 0.012 
Levels decompressed -0.067 0.052 -1.289 170.875 0.199 
 
BMI, body mass index; CIRS, Cumulative Illness Rating Scale (range 0-56, best-worst); HADS, Hospital Anxiety and Depression Scale 
(range 0-21, best-worst); SSM, Spinal Stenosis Measure 
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Appendix Table 1b: Multiple linear regression model for SSM symptoms at 24-month 
follow-up 
Variable estimate std.error statistic df p.value 
(Intercept) 2.422 0.163 14.856 171.017 0.000 
Age 0.008 0.007 1.077 170.951 0.283 
BMI 0.012 0.016 0.788 170.602 0.432 
SEL 0.439 0.217 2.020 170.832 0.045 
SSM symptoms 0.328 0.102 3.216 170.941 0.002 
Male -0.164 0.120 -1.366 170.561 0.174 
Epidural injection 
within 6 months be-
fore baseline 
-0.047 0.125 -0.379 170.772 0.705 
CIRS 0.031 0.015 2.045 170.821 0.042 
HADS depression 0.044 0.018 2.420 164.999 0.017 
Levels decompressed -0.053 0.071 -0.753 170.850 0.453 
 
BMI, body mass index; CIRS, Cumulative Illness Rating Scale (range 0-56, best-worst); HADS, Hospital Anxiety and Depression Scale 
(range 0-21, best-worst); SSM, Spinal Stenosis Measure 
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Appendix Table 1c: Multiple linear regression model for EQ-5D-3L SI at 24-month fol-
low-up 
Variable estimate std.error statistic df p.value 
(Intercept) 0.772 0.049 15.732 171.017 0.000 
Age -0.002 0.002 -0.799 170.895 0.425 
BMI -0.009 0.005 -1.934 169.896 0.055 
SEL -0.141 0.066 -2.153 170.591 0.033 
EQ-5D-3L SI 0.111 0.065 1.699 169.981 0.091 
Male 0.010 0.036 0.291 170.183 0.772 
Epidural injection 
within 6 months be-
fore baseline 
-0.027 0.038 -0.709 170.288 0.479 
CIRS -0.009 0.005 -1.887 170.500 0.061 
HADS depression -0.022 0.006 -3.871 157.734 0.000 
Levels decompressed -0.010 0.021 -0.465 170.658 0.642 
 
BMI, body mass index; CIRS, Cumulative Illness Rating Scale (range 0-56, best-worst); HADS, Hospital Anxiety and Depression Scale 
(range 0-21, best-worst); SI, summary index 
